漏 2025 91福利

1375 Euclid Avenue, Cleveland, Ohio 44115
(216) 916-6100 | (877) 399-3307

WKSU is a public media service licensed to and operated by 91福利.
srcset=https://npr.brightspotcdn.com/dims4/default/8092df9/2147483647/strip/true/crop/2880x210+0+0/resize/2880x210!/quality/90/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fbb%2Ffb%2F1f301c58444e92773b55525d4569%2Fipm-pinwheel-pattern.png
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

ARDS

  • srcset=https://npr.brightspotcdn.com/dims4/default/d24eb69/2147483647/strip/true/crop/1308x729+54+0/resize/560x312!/quality/90/?url=https%3A%2F%2Fideastream-production.s3.amazonaws.com%2Fuploads%2F2020%2F3%2F26%2FAthersys_cleveland.PNG
    Health
    UH, Athersys Testing Possible Therapy For Deadly COVID-19 Complication
    Updated on May 1, 2020 at 12pm Athersys, a biotechnology company in Cleveland, has been developing a possible therapy for serious medical conditions such as acute respiratory distress syndrome (ARDS) 鈥� one of the more concerning complications caused by COVID-19. The company announced in a press release on Friday May 1, 2020, that University Hospitals is starting a clinical trial testing the effectiveness of this treatment on patients with COVID-19 induced ARDS.